D.E. Shaw & Co’s St Jude Medical STJ Stock Holding History

D.E. Shaw & Co’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-10,000	Closed	-$618K	–	4008
2015 Q4	$618K	Hold	10,000	–	–	﹤0.01%	2951
2015 Q3	$631K	Hold	10,000	–	–	﹤0.01%	2913
2015 Q2	$731K	Hold	10,000	–	–	﹤0.01%	2918
2015 Q1	$654K	Sell	10,000 -76,800	-88%	-$5.11M	﹤0.01%	2893
2014 Q4	$5.64M	Hold	86,800	–	–	0.01%	1473
2014 Q3	$5.22M	Hold	86,800	–	–	0.01%	1539
2014 Q2	$6.01M	Buy	86,800 +10,000	+13%	+$648K	0.01%	1480
2014 Q1	$5.02M	Sell	76,800 -12,300	-14%	-$801K	0.01%	1579
2013 Q4	$5.52M	Buy	89,100 +26,800	+43%	+$1.55M	0.01%	1594
2013 Q3	$3.34M	Buy	+62,300	New	+$3.21M	0.01%	1971

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

D.E. Shaw & Co's STJ Position: Q1 2017 in Review

D.E. Shaw & Co sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 21,204 shares — an estimated $1.7M sold.

D.E. Shaw & Co first reported a position in STJ in Q3 2013 and held it in 13 quarters. The position peaked at $113M in Q2 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

D.E. Shaw & Co reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
D.E. Shaw & Co sold 21,204 St Jude Medical shares in Q1 2017, an estimated $1.7M.
D.E. Shaw & Co first reported a position in St Jude Medical in Q3 2013 and held it in 13 quarters.
D.E. Shaw & Co's St Jude Medical position peaked at $113M in Q2 2016.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on D.E. Shaw & Co's 13F filing for Q1 2017, filed 15 May 2017.